Monitoring the transition of patients on biologics in rheumatoid arthritis: Consensus guidance for pharmacists

Background: Recent approvals for novel agents such as the small molecule Janus kinase inhibitors (JAKi), combined with the advent of biosimilars has widened the gamut of available therapeutic options in the treatment of rheumatoid arthritis (RA). This combined with the introduction of mandatory non-...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Denis Choquette (Egilea), Jonathan Chan (Egilea), Mohammad Bardi (Egilea), Carolyn Whiskin (Egilea), Gabriel Torani (Egilea), Brennan K. Smith (Egilea), Aaron Sihota (Egilea)
Formatua: Liburua
Argitaratua: Centro de Investigaciones y Publicaciones Farmaceuticas, 2021-09-01T00:00:00Z.
Gaiak:
Sarrera elektronikoa:Connect to this object online.
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Internet

Connect to this object online.

3rd Floor Main Library

Aleari buruzko argibideak 3rd Floor Main Library
Sailkapena: A1234.567
Alea 1 Eskuragarri